| 000 | 01669 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514045449.0 | ||
| 264 | 0 | _c20030402 | |
| 008 | 200304s 0 0 eng d | ||
| 022 | _a1352-4585 | ||
| 024 | 7 |
_a10.1191/1352458502ms836oa _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGhalie, R G | |
| 245 | 0 | 0 |
_aA study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosis. _h[electronic resource] |
| 260 |
_bMultiple sclerosis (Houndmills, Basingstoke, England) _cOct 2002 |
||
| 300 |
_a441-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis; Review | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aClinical Trials, Phase III as Topic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFrance |
| 650 | 0 | 4 | _aGermany |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 |
_aLeukemia _xchemically induced |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMedical Records |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMitoxantrone _xadministration & dosage |
| 650 | 0 | 4 | _aMulticenter Studies as Topic |
| 650 | 0 | 4 |
_aMultiple Sclerosis _xdrug therapy |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aRetrospective Studies |
| 700 | 1 | _aMauch, E | |
| 700 | 1 | _aEdan, G | |
| 700 | 1 | _aHartung, H P | |
| 700 | 1 | _aGonsette, R E | |
| 700 | 1 | _aEisenmann, S | |
| 700 | 1 | _aLe Page, E | |
| 700 | 1 | _aButine, M D | |
| 700 | 1 | _aDe Goodkin, D E | |
| 773 | 0 |
_tMultiple sclerosis (Houndmills, Basingstoke, England) _gvol. 8 _gno. 5 _gp. 441-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1191/1352458502ms836oa _zAvailable from publisher's website |
| 999 |
_c12168525 _d12168525 |
||